Cn / En

CM05182


CM05182

Key word胰腺癌, PDX, 体内药效,体外药效,免疫系统人源化,奥拉帕利, 奥沙利铂, 奥希替尼, 厄洛替尼, 吉西他滨, 曲美替尼, 顺铂, 依维莫司, 紫杉醇,

Model Information

Model IDCM05182
Cancer Type胰腺癌
Cell Subtype腺癌
Differentiation中低分化
Collection SiteHead
Metastatic Site 
GradeIII
TNM stagingT3NxM0
IHC diagnosis

胰头颈肿瘤免疫组化标记结果:

CAM5.2(+) Muc-5(弱+) MSH6(100%)? S-100(+)

CK8/18(+) Muc-6(弱+) PMS2(100%) CD4(肿瘤间部分淋巴细胞+)

CK19(部分+) CDX2(-) PD.1(-) CD8(肿瘤间少量淋巴细胞+)

Muc-1(+) MLH1(100%) PDL.1(-) Ki-67(30%)

Muc-2(-) MSH2(100%) P53(90%) P40(-)

诊断:(胰头)导管腺癌

Pathology diagnosis1、(胰头)中-低分化导管腺癌,肿瘤最大径4.8cm 2、(胆囊)慢性炎 3、(脾脏)呈慢性淤血性改变。,
Clinical Treatment Records 

Model Data

Histopathological Images

 

Tumor growth curve

In vivo efficacy of SOCs

  
  
  
  

In vitro efficacy of SOCs